NYSE:AMRX
Amneal Pharmaceuticals, Inc. Stock News
$6.68
-0.100 (-1.47%)
At Close: May 31, 2024
Parametric Portfolio Associates LLC Grows Stock Position in Amneal Pharmaceuticals Inc (NYSE:AMRX)
04:28am, Sunday, 05'th Jul 2020
Parametric Portfolio Associates LLC grew its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 17.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 236,760 shares of the compa
51,034 Shares in Amneal Pharmaceuticals Inc (NYSE:AMRX) Acquired by Voloridge Investment Management LLC
07:28am, Saturday, 04'th Jul 2020
Voloridge Investment Management LLC bought a new position in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) during the first quarter, according to its most recent Form 13F filing with the SEC. The f
Alliancebernstein L.P. Sells 19,700 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
06:44am, Saturday, 04'th Jul 2020
Alliancebernstein L.P. reduced its stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 8.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Co
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Pfizer (NYSE: PFE) - Markets
03:52pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX
How R&D Expenses Can Help You Pick Outperforming Stocks
12:13pm, Thursday, 02'nd Jul 2020
A simple two-rule screen can help you pick R&D-intensive stocks primed to outperform. The differences between R&D expenditures and capital expenditures vary bet
CytoDyn Signs MOU With NIH of Mexico for Coronavirus Study
02:21pm, Tuesday, 30'th Jun 2020
CytoDyn's (CYDY) shares rise more than 20% as it inks an MOU with NIH of Mexico to conduct a COVID-19 study on leronlimab.
Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment
02:48pm, Friday, 26'th Jun 2020
Zogenix (ZGNX) gets FDA nod for Fintepla oral solution, CIV for the treatment of seizures associated with Dravet Syndrome in patients 2 years of age or older.
Balyasny Asset Management LLC Purchases Shares of 24,151 Amneal Pharmaceuticals Inc (NYSE:AMRX)
07:00am, Friday, 26'th Jun 2020
Balyasny Asset Management LLC purchased a new stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) during the first quarter, according to the company in its most recent 13F filing with the SEC. T
AMRX vs. COLL: Which Stock Should Value Investors Buy Now?
03:40pm, Friday, 19'th Jun 2020
AMRX vs. COLL: Which Stock Is the Better Value Option?
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Moves 5.6% Higher
12:33pm, Tuesday, 16'th Jun 2020
Jazz Pharmaceuticals (JAZZ) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
IN BRIEF: Supreme Court will not hear generic drug price fixing discovery dispute
08:03pm, Monday, 15'th Jun 2020
The U.S. Supreme Court on Monday declined to hear generic drugmakers' challenge to a court order requiring them to turn over millions of pages of records to states and drug purchasers accusing them of
Amneal Pharmaceuticals (AMRX): Hedge Funds Never Been Less Bullish
01:33am, Monday, 15'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Alprazolam Market 2020-2024 | Increasing Prevalence of Anxiety Disorders to Boost Growth | Technavio
12:00am, Saturday, 13'th Jun 2020
The Global Alprazolam Market will grow by USD 90.33 mn during 2020-2024
Moving Average Crossover Alert: Amneal Pharmaceuticals
12:49pm, Friday, 12'th Jun 2020
Amneal Pharmaceuticals, Inc. (AMRX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Drug Makers Conspired To Fix Prices: CT Attorney General
11:02am, Thursday, 11'th Jun 2020
Drug Makers Conspired To Fix Prices: CT AG - Across Connecticut, CT - Connecticut Attorney General William Tong led 51 states and territories in filing a suit alleging price manipulation of generic dr